MPI Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

MPI Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$496K	Buy	+8,088	New	+$506K	0.59%	50

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MPI Investment Management's BMY Position: Q4 2017 in Review

MPI Investment Management opened a new position in Bristol-Myers Squibb (BMY) in Q4 2017: 8,088 shares worth $496K. The stake represents 0.59% of the portfolio and ranks #50 among its holdings.

1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

MPI Investment Management held 8,088 shares of Bristol-Myers Squibb worth $496K as of Q4 2017.
Bristol-Myers Squibb was a new MPI Investment Management position in Q4 2017.
Bristol-Myers Squibb made up 0.59% of MPI Investment Management's portfolio in Q4 2017, its #50 holding.
1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on MPI Investment Management's 13F filing for Q4 2017, filed 6 Feb 2018.